The role of Iodine-123-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis

International Journal of Cardiology

Volumn 94, Issue 1, 2004, Pages 99-103

  Kaminaga, Tatsuro ^a   Takeshita, Touru ^b   Yamauchi, Teiyu ^b   Kawamura, Hikaru ^b   Yasuda, Masami ^b  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

15 (p Iodophenyl) 3R,S methylpentadecanoic acid; Cardiac involvement; Echocardiography; Sarcoidosis; Thallium chloride

Indexed keywords

15 (4 IODOPHENYL)METHYLPENTADECANOIC ACID; DECANOIC ACID DERIVATIVE; IODINE 123; THALLIUM 201; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOACCUMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE; HEART VENTRICLE WALL; HUMAN; INTERMETHOD COMPARISON; ISOTOPE LABELING; MALE; MYOCARDIAL DISEASE; MYOCARDIAL SARCOIDOSIS; PREDICTION; PRIORITY JOURNAL; SARCOIDOSIS; SCINTIGRAPHY; SPECTRAL SENSITIVITY;

CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; FATTY ACIDS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 1542346903     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.05.012     Document Type: Article

References (25)

1. Shammas R.L., Movahed A. Sarcoidosis of the heart. Clin. Cardiol. 16:1993;462-472.
2. Newman L.S., Rose C.S., Maier L.A. Sarcoidosis. N. Engl. J. Med. 336:1997;1224-1235.
3. Silverman K.J., Hutchins G.M., Bulkley B.H. Cardiac sarcoidosis: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 58:1978;1204-1211.
4. Matsui Y., Iwai K., Tachibana T.et al. Clinicopathological study on fatal myocardial sarcoidosis. Ann. N.Y. Acad. Sci. 278:1976;455-469.
5. Roberts W.C., McAllister H.A., Ferrans V. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients and review of 78 previously described necropsy patients. Am. J. Med. 63:1977;86-108.
6. Iwai K., Sekiguti M., Hosoda Y.et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis. 11:1994;26-31.
7. Wynne J., Braunward E. The cardiomyopathies and myocarditis. Braunward E. Heart disease; a textbook of cardiovascular medicine. 2nd ed. 1984;1426-1427 Saunders, Philadelphia PA.
8. Bulkley B.H., Rouleau J.R., Whitaker J.Q.et al. The use of 201 thallium for myocardial perfusion imaging in sarcoid heart disease. Chest. 72:1977;27-32.
9. Tachibana T., Ohmori F., Ueda E. Clinical study on cardiac sarcoidosis. Ann. N.Y. Acad. Sci. 465:1986;530-542.
10. Perry A., Vuitch F. Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch. Pathol. Lab. Med. 119:1995;167-172.
11. Goodman M.M., Kirsch G., Knapp F.F. Jr. Synthesis and evaluation of radioiodinated terminal p-iodophenyl-substituted alpha- and beta-methyl- branched fatty acids. J. Med. Chem. 27:1984;390-397.
12. Nohara R., Hosokawa R., Hirai T.et al. Effect of metabolic substrate on BMIPP metabolism in canine myocardium. J. Nucl. Med. 39:1998;1132-1137.
13. Ogata M. Myocardial uptake of 125I-BMIPP in rats treated with adriamycin. Kaku Igaku. 26:1989;69-76.
14. Hosokawa R., Nohara R., Fujibayashi Y.et al. Metabolic fate of iodine-123-BMIPP in canine myocardium after administration of etomoxir. J. Nucl. Med. 37:1996;1836-1840.
15. Fujibayashi Y., Yonekura Y., Kawai K.et al. Basic studies on I-123-beta-methyl-p-iodophenylpentadecanoic acid (BMIPP) for myocardial functional diagnosis: effect of beta-oxidation inhibitor. Kaku Igaku. 25:1988;1131-1135.
16. Nohara R., Hosokawa R., Hirai T.et al. Effect of metabolic substrate on BMIPP metabolism in canine myocardium. J. Nucl. Med. 39:1998;1132-1137.
17. Uemura A., Morimoto S., Hiramitsu S.et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am. Heart J. 138(2 Pt 1):1999;299-302.
18. Shammas R.L., Movahed A. Sarcoidosis of the heart. Clin. Cardiol. 16:1993;462-472.
19. Valantine H., McKenna W.J., Nihoyannopoulos P.et al. Sarcoidosis: a pattern of clinical and morphological presentation. Br. Heart J. 57:1987;256-263.
20. Makler P.T., Lavine S.J., Denenberg B.S., Bove A.A., Idell S. Redistribution on the thallium scan in myocardial sarcoidosis: concise communication. J. Nucl. Med. 22:1981;428-432.
21. Tellier P., Valeyre D., Nitenberg A.et al. Cardiac sarcoidosis: reversion of myocardial perfusion abnormalities by dipyridamole. Eur. J. Nucl. Med. 11:1985;201-204.
22. Tellier P., Paycha F., Antony I.et al. Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am. J. Med. 85:1988;189-193.
23. Wait J.L., Movahed A. Anginal chest pain in sarcoidosis. Thorax. 44:1989;391-395.
24. Mikami R., Sekiguchi M., Ryuzin Y.et al. Changes in the peripheral vasculature of various organs in patients with sarcoidosis - possible role of microangiopathy. Heart Vessels. 2:1986;129-139.
25. Takemura T., Matsui Y., Oritsu M.et al. Pulmonary vascular involvement in sarcoidosis: granulomatous angiitis and microangiopathy in transbronchial lung biopsies. Virchows Arch., A Pathol. Anat. Histopathol. 418:1991;361-368.